ChemicalBook >> CAS DataBase List >>(+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM

(+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM

CAS No.
1021868-76-7
Chemical Name:
(+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM
Synonyms
CR 1409 SODIUM;LORGLUMIDE SODIUM;CR-1409 sodium salt;LORGLUMIDE SODIUM SALT;sodium:4-[(3,4-dichlorobenzoyl)amino]-5-(dipentylamino)-5-oxopentanoate;(+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM;(+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM
CBNumber:
CB2176642
Molecular Formula:
C22H33Cl2N2NaO4
Molecular Weight:
483.41
MDL Number:
MFCD00083183
MOL File:
Mol file
Last updated:2023-05-18 11:31:12

(+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM Properties

Melting point >229°C (dec.)
storage temp. Hygroscopic, -20°C Freezer, Under inert atmosphere
solubility 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: >10 mg/mL
form solid
color white
Stability Hygroscopic

SAFETY

Risk and Safety Statements

WGK Germany  2
RTECS  SA3680700

(+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM price More Price(14)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich L109 Lorglumide sodium salt solid 1021868-76-7 50mg $192 2024-03-01 Buy
Sigma-Aldrich L109 Lorglumide sodium salt solid 1021868-76-7 250mg $712 2023-06-20 Buy
Cayman Chemical 17555 Lorglumide (sodium salt) ≥98% 1021868-76-7 5mg $32 2024-03-01 Buy
Cayman Chemical 17555 Lorglumide (sodium salt) ≥98% 1021868-76-7 10mg $50 2024-03-01 Buy
Cayman Chemical 17555 Lorglumide (sodium salt) ≥98% 1021868-76-7 25mg $86 2024-03-01 Buy
Product number Packaging Price Buy
L109 50mg $192 Buy
L109 250mg $712 Buy
17555 5mg $32 Buy
17555 10mg $50 Buy
17555 25mg $86 Buy

(+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM Chemical Properties,Uses,Production

Uses

Lorglumide sodium salt has been used as a cck-a (cholecystokinin A) receptor antagonist for peptide determination in rat islet cells. It has been used as a CCK1 inhibitor to check the effect of cck1 (cck-a) and cck2 (cck-b) receptors on cerulein-induced upregulation of egr-1 (early growth response 1) expression in rat pancreatic acinar cells.

Biological Activity

lorglumide (sodium salt) is the first nonpeptidic, selective and potent inhibitor of the cck-a receptor [1][2][3][4] .cholecystokinin (cck) is a peptide hormone that plays important roles in the physiological regulation of pancreatic enzyme secretion, induction of pancreatic growth, smooth muscle contraction in the gall bladder and stomach, and modulation of feeding and behavior [1][2][3].lorglumide (cr1409) is the first nonpeptidic, selective and potent inhibitor of the cck-a receptor. lorglumide inhibited cck a receptor and cck b receptor with ic50 values of 50 nm and 3 μm, respectively [4]. in the guinea-pig isolated ileum, lorglumide (0.06-2.1 μm) antagonized longitudinal muscle responses to ceruletide (a cck-related decapeptide) and cck-octapeptide (cck-8) in a concentration dependent and competitive manner. lorglumide (0.2-0.4 μm) also blocked contractions of the circular muscle induced by ceruletide [2].in mice, cr1409 completely abolished the trophic effects of exogenous cck and significantly inhibited the effects of chronic camostate feeding. cr1409 reduced pancreatic weight, dna and protein content [3].

Biochem/physiol Actions

Potent and selective non-peptide cholecystokinin (CCKA) receptor antagonist; orally active.

References

[1]. makovec f, peris w, revel l, et al. structure-antigastrin activity relationships of new (r)-4-benzamido-5-oxopentanoic acid derivatives. j med chem. 1992 jan;35(1):28-38.
[2]. barthó l, holzer p, lembeck f, et al. evaluation of a new and potent cholecystokinin antagonist on motor responses of the guinea-pig intestine. br j pharmacol. 1987 apr;90(4):753-61.
[3]. niederau c, liddle ra, williams ja, et al. pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. gut. 1987;28 suppl:63-9.
[4]. scarpignato c, varga g, dobronyi i, et al. effect of a new potent cck antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat. br j pharmacol. 1989 mar;96(3):661-9.

(+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM Preparation Products And Raw materials

Raw materials

Preparation Products

(+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM Suppliers

Global( 40)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 19892 58
Aladdin Scientific
+1-833-552-7181 sales@aladdinsci.com United States 52927 58
3B Pharmachem (Wuhan) International Co.,Ltd. 821-50328103-801 18930552037 3bsc@sina.com China 15848 69
Sigma-Aldrich 021-61415566 800-8193336 orderCN@merckgroup.com China 51471 80
Fan De(Beijing) Biotechnology Co., Ltd. 15911056312 liming@bio-fount.com China 9730 58
BOC Sciences -- info@bocsci.com USA 0 65
Energy Chemical 021-58432009 400-005-6266 marketing1@energy-chemical.com China 44894 58
cjbscvictory 13348960310 13348960310 3003867561@qq.com China 9946 58
Beijing Jin Ming Biotechnology Co., Ltd. 010-60605840 15801484223 psaitong@jm-bio.com China 29834 58
TargetMol Chemicals Inc. 4008200310 marketing@tsbiochem.com China 24131 58

1021868-76-7((+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM)Related Search:

CR 1409 SODIUM LORGLUMIDE SODIUM LORGLUMIDE SODIUM SALT (+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM CR-1409 sodium salt sodium:4-[(3,4-dichlorobenzoyl)amino]-5-(dipentylamino)-5-oxopentanoate (+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM 1021868-76-7 C22H31Cl2N2O4Na